Meh. Down a cent or two on low volume. It was overvalued prior to the FS in the current state. Expectations were too high. Don’t know the average share price for you and others, but I like the chances for a relatively quick rebound right here for a 2x-3x return. With Friedland’s backing, the fact that they bought the autoclaves prior to the FS, and the merits of Co and Ni, I’m pretty confident that the discussions within the board room are still pretty positive. No need to overshoot on the FS and leave yourself exposed when all other systems are a go.